rs41299623

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_018136.5(ASPM):​c.5185C>T​(p.Arg1729Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00965 in 1,612,828 control chromosomes in the GnomAD database, including 111 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1729Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0083 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0098 ( 100 hom. )

Consequence

ASPM
NM_018136.5 missense

Scores

3
6
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 2.85

Publications

22 publications found
Variant links:
Genes affected
ASPM (HGNC:19048): (assembly factor for spindle microtubules) This gene is the human ortholog of the Drosophila melanogaster 'abnormal spindle' gene (asp), which is essential for normal mitotic spindle function in embryonic neuroblasts. Studies in mouse also suggest a role of this gene in mitotic spindle regulation, with a preferential role in regulating neurogenesis. Mutations in this gene are associated with microcephaly primary type 5. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2011]
ASPM Gene-Disease associations (from GenCC):
  • microcephaly 5, primary, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004125327).
BP6
Variant 1-197104066-G-A is Benign according to our data. Variant chr1-197104066-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 95889.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00827 (1257/151970) while in subpopulation AMR AF = 0.0148 (225/15214). AF 95% confidence interval is 0.0132. There are 11 homozygotes in GnomAd4. There are 608 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASPMNM_018136.5 linkc.5185C>T p.Arg1729Trp missense_variant Exon 18 of 28 ENST00000367409.9 NP_060606.3 Q8IZT6-1B3KWI2
ASPMNM_001206846.2 linkc.4066-7902C>T intron_variant Intron 17 of 26 NP_001193775.1 Q8IZT6-2B3KWI2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASPMENST00000367409.9 linkc.5185C>T p.Arg1729Trp missense_variant Exon 18 of 28 1 NM_018136.5 ENSP00000356379.4 Q8IZT6-1

Frequencies

GnomAD3 genomes
AF:
0.00828
AC:
1257
AN:
151852
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00159
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0148
Gnomad ASJ
AF:
0.0165
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00891
Gnomad FIN
AF:
0.00236
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0117
Gnomad OTH
AF:
0.0173
GnomAD2 exomes
AF:
0.00955
AC:
2390
AN:
250290
AF XY:
0.0101
show subpopulations
Gnomad AFR exome
AF:
0.00136
Gnomad AMR exome
AF:
0.0110
Gnomad ASJ exome
AF:
0.0185
Gnomad EAS exome
AF:
0.000762
Gnomad FIN exome
AF:
0.00219
Gnomad NFE exome
AF:
0.0115
Gnomad OTH exome
AF:
0.0156
GnomAD4 exome
AF:
0.00979
AC:
14307
AN:
1460858
Hom.:
100
Cov.:
38
AF XY:
0.0101
AC XY:
7330
AN XY:
726756
show subpopulations
African (AFR)
AF:
0.00135
AC:
45
AN:
33430
American (AMR)
AF:
0.0109
AC:
485
AN:
44638
Ashkenazi Jewish (ASJ)
AF:
0.0190
AC:
497
AN:
26104
East Asian (EAS)
AF:
0.000479
AC:
19
AN:
39674
South Asian (SAS)
AF:
0.0125
AC:
1074
AN:
86228
European-Finnish (FIN)
AF:
0.00267
AC:
142
AN:
53166
Middle Eastern (MID)
AF:
0.0224
AC:
129
AN:
5764
European-Non Finnish (NFE)
AF:
0.0102
AC:
11302
AN:
1111512
Other (OTH)
AF:
0.0102
AC:
614
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
919
1839
2758
3678
4597
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00827
AC:
1257
AN:
151970
Hom.:
11
Cov.:
32
AF XY:
0.00818
AC XY:
608
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.00161
AC:
67
AN:
41514
American (AMR)
AF:
0.0148
AC:
225
AN:
15214
Ashkenazi Jewish (ASJ)
AF:
0.0165
AC:
57
AN:
3464
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5156
South Asian (SAS)
AF:
0.00912
AC:
44
AN:
4822
European-Finnish (FIN)
AF:
0.00236
AC:
25
AN:
10598
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0117
AC:
794
AN:
67896
Other (OTH)
AF:
0.0171
AC:
36
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
65
130
196
261
326
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0100
Hom.:
48
Bravo
AF:
0.00844
TwinsUK
AF:
0.00890
AC:
33
ALSPAC
AF:
0.0125
AC:
48
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.0135
AC:
116
ExAC
AF:
0.00963
AC:
1169
Asia WGS
AF:
0.00462
AC:
17
AN:
3478
EpiCase
AF:
0.0143
EpiControl
AF:
0.0145

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ASPM: PM5, BP4, BS1, BS2 -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
Jul 03, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 05, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcephaly 5, primary, autosomal recessive Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Sep 05, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ASPM-related disorder Benign:1
Mar 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.37
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.34
T
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.91
D
MetaRNN
Benign
0.0041
T
MetaSVM
Benign
-0.57
T
MutationAssessor
Pathogenic
3.7
H
PhyloP100
2.8
PrimateAI
Benign
0.24
T
PROVEAN
Uncertain
-4.0
D
REVEL
Benign
0.28
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0010
D
Polyphen
1.0
D
Vest4
0.39
MVP
0.33
ClinPred
0.083
T
GERP RS
6.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.40
gMVP
0.089
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41299623; hg19: chr1-197073196; COSMIC: COSV99038474; API